Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 92, Issue 2, Pages 235-242
Publisher
Springer Nature
Online
2012-06-28
DOI
10.1038/clpt.2012.66
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detecting Drug Interactions From Adverse-Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose Levels
- (2011) N P Tatonetti et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenomics at the Tipping Point: Challenges and Opportunities
- (2011) D M Roden et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record
- (2011) J T Delaney et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Electronic Medical Records for Genetic Research: Results of the eMERGE Consortium
- (2011) A. N. Kho et al. Science Translational Medicine
- Cost-Effectiveness of Zoledronic Acid Plus Endocrine Therapy in Premenopausal Women With Hormone-Responsive Early Breast Cancer
- (2010) Thomas E. Delea et al. Clinical Breast Cancer
- Assessing the accuracy of observer-reported ancestry in a biorepository linked to electronic medical records
- (2010) Logan Dumitrescu et al. GENETICS IN MEDICINE
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MedEx: a medication information extraction system for clinical narratives
- (2010) H. Xu et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data
- (2010) M. J. SORICH et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The Path to Personalized Medicine
- (2010) Margaret A. Hamburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hospitalization costs associated with warfarin-related bleeding events among older community-dwelling adults
- (2010) Michelle M. Kim et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA
- (2010) Lawrence J Lesko et al. PHARMACOGENOMICS
- Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?
- (2010) Jenny E Higgs et al. PHARMACOGENOMICS
- Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation
- (2009) Amanda R. Patrick et al.
- Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
- (2009) Werner Schroth JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Opportunities and Challenges for the NIH — An Interview with Francis Collins
- (2009) Robert Steinbrook NEW ENGLAND JOURNAL OF MEDICINE
- A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
- (2009) Lisa M. Meckley et al. PHARMACOECONOMICS
- The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV
- (2008) Bruce R Schackman et al. AIDS
- Multi-mutational analysis of fifteen common mutations of the glucose 6-phosphate dehydrogenase gene in the Mediterrranean population
- (2008) Ma Esther Farez-Vidal et al. CLINICA CHIMICA ACTA
- Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized Medicine
- (2008) DM Roden et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use
- (2008) Felix W Frueh et al. PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started